Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

被引:472
|
作者
Trapp, Bruce D. [1 ]
Stys, Peter K. [2 ]
机构
[1] Lerner Res Inst, Cleveland Clin, Dept Neurosci NC30, Cleveland, OH 44195 USA
[2] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 03期
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAGNETIC-RESONANCE-SPECTROSCOPY; CORD WHITE-MATTER; ADAPTIVE FUNCTIONAL-CHANGES; NITRIC-OXIDE; NMDA RECEPTORS; NEUROLOGICAL DISABILITY; GLUTAMATE RECEPTORS; MYELINATED AXONS; SODIUM-CHANNELS;
D O I
10.1016/S1474-4422(09)70043-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS), an inflammatory demyelinating disease, is a major cause of neurological disability in young adults in the developed world. Although the progressive neurological disability that most patients with MS eventually experience results from axonal degeneration, little is known about the mechanisms of axonal injury in MS. Accumulating evidence suggests that the increased energy demand of impulse conduction along excitable demyelinated axons and reduced axonal ATP production induce a chronic state of virtual hypoxia in chronically demyelinated axons. In response to such a state, key alterations that contribute to chronic necrosis of axons might include mitochondrial dysfunction (due to defective oxidative phosphorylation or nitric oxide production), Na+ influx through voltage-gated Na+ channels and axonal AMPA receptors, release of toxic Ca2+ from the axoplasmic reticulum, overactivation of ionotropic and metabotropic axonal glutamate receptors, and activation of voltage-gated Ca2+ channels, ultimately leading to excessive stimulation of Ca2+-dependent degradative pathways. The development of neuroprotective therapies that target these mechanisms might constitute effective adjuncts to currently used immune-modifying agents.
引用
收藏
页码:280 / 291
页数:12
相关论文
共 50 条
  • [21] Virtual Reality as an Intervention for Chronic Pain in Multiple Sclerosis
    Malik, Martin
    Shaw, Michael
    Palmeri, Maria
    Charvet, Leigh
    NEUROLOGY, 2021, 96 (15)
  • [22] Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis
    Wolswijk, G
    Balesar, R
    BRAIN, 2003, 126 : 1638 - 1649
  • [23] Multinucleated astrocytes in old demyelinated plaques in a patient with multiple sclerosis
    Nishie, M
    Mori, F
    Ogawa, M
    Sannohe, S
    Tanno, K
    Kurahashi, K
    Kuroda, N
    Wakabayashi, K
    NEUROPATHOLOGY, 2004, 24 (03) : 248 - 253
  • [24] Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord
    Wolswijk, G
    BRAIN, 2002, 125 : 338 - 349
  • [25] SINGLE-CHANNEL CHARACTERIZATION OF MULTIPLE TYPES OF POTASSIUM CHANNELS IN DEMYELINATED XENOPUS AXONS
    WU, JV
    RUBINSTEIN, CT
    SHRAGER, P
    JOURNAL OF NEUROSCIENCE, 1993, 13 (12): : 5153 - 5163
  • [26] Brain damage outside demyelinated white matter plaques in multiple sclerosis
    Kutzelnigg, AE
    Lucchinetti, CF
    Stadelmann, C
    Brück, W
    Rauschka, H
    Bergmann, M
    Schmidbauer, M
    Parisi, J
    Lassmann, H
    MULTIPLE SCLEROSIS, 2005, 11 : S5 - S5
  • [27] Mitochondrial changes within axons in multiple sclerosis
    Mahad, Don J.
    Ziabreva, Iryna
    Campbell, Graham
    Lax, Nichola
    White, Katherine
    Hanson, Peter S.
    Lassmann, Hans
    Turnbull, Douglass M.
    BRAIN, 2009, 132 : 1161 - 1174
  • [28] INCREASE OF SODIUM-CHANNELS IN DEMYELINATED LESIONS OF MULTIPLE-SCLEROSIS
    MOLL, C
    MOURRE, C
    LAZDUNSKI, M
    ULRICH, J
    BRAIN RESEARCH, 1991, 556 (02) : 311 - 316
  • [29] Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosis
    Absinta, Martina
    Ontaneda, Daniel
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (02) : 135 - 136
  • [30] Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis
    Gray, Elizabeth
    Thomas, Taya L.
    Betmouni, Samar
    Scolding, Neil
    Love, Seth
    BRAIN PATHOLOGY, 2008, 18 (01) : 86 - 95